S

Subsense

Develops noninvasive nanotech BCI devices

Head of Partnerships

Business Development & PartnershipsUpdated on Nov 12
Full-timePalo Alto, CA, USAIn-person

About the Job

Requirements

  • At least 8 years of experience in strategic partnerships, platform partnerships, or corporate development.
  • A proven ability to structure and secure partnerships that deliver tangible outcomes, including access to data, infrastructure, and distribution channels.
  • A proven track record of closing 0-to-1 partnerships with major technology companies.
  • Experience selling pre-product, platform, or deep-tech concepts.
  • Ability to engage vice president and C-suite stakeholders.

Responsibilities

  • Define partnership strategy, including build-versus-buy-versus-partner decisions, and prioritize the highest-leverage opportunities.
  • Identify, engage, and close strategic partnerships with top-tier technology companies, including hyperscalers, AI labs, and platform providers.
  • Build and manage senior relationships across product, research, and corporate development teams.
  • Originate and structure letters of intent, pilot agreements, and joint development partnerships before the product exists.
  • Translate early-stage science into compelling commercial narratives tailored to technical and executive audiences.
  • Drive measurable partnership outcomes, including access to data, infrastructure, and distribution channels.
  • Own partnership key performance indicators, including the number of letters of intent, pilots, and strategic integrations secured.

Desired Qualifications

  • A background in artificial intelligence, infrastructure, developer platforms, or frontier technology is strongly preferred.

About the Company

Subsense

Develops noninvasive nanotech BCI devices

Subsense develops nanotechnology-based noninvasive brain-computer interfaces and medical devices aimed at treating neurodegenerative diseases. Its products are designed for daily, seamless use in healthcare, combining brain signal interfaces with nanotech to aid patients and clinicians. The company works with academic experts from ETH Zurich and Stanford to guide research and development, and plans to sell or license its BCI devices in Europe and the USA. Compared with competitors, Subsense emphasizes noninvasive, nano-scale interfaces and strong collaborations to translate research into market-ready medical devices. The overarching goal is to improve quality of life for individuals with neurodegenerative conditions by delivering practical, clinician-friendly BCI solutions.

Company size
11-50
Company stage
Early VC
Total funding
$27M
Headquarters
Palo Alto, CA
Founded
2022

Recently Posted Jobs

Explore more opportunities at Subsense

See more jobs